The Peripheral T-Cell Lymphomas. Группа авторов
target="_blank" rel="nofollow" href="#ulink_b21ecb42-53c9-5405-a1e5-4d69770cb30a">Angioimmunoblastic T‐cell Lymphoma and Other T Follicular Helper‐derived Malignancies Anaplastic Large‐cell Lymphomas Adult T‐cell Leukemia/Lymphoma Peripheral T‐cell Lymphoma Not Otherwise Specified Hepatosplenic T‐cell Lymphoma Extranodal natural killer/T‐cell Lymphoma Cutaneous T‐cell Lymphomas Conclusion Must Reads References
8
Part III: Discrete Clinical Subtypes of PTCL (Unique Epidemiology, Therapy and Management)
8 Peripheral T‐cell Lymphoma Not Otherwise Specified
Introduction
Epidemiology, Risk Factors, and Clinical Characteristics
Basic Principles of Disease Biology
Prognostic Tools
Frontline Therapy
Management of Relapsed or Refractory Disease
Future Directions
Must Reads
References
9 Angioimmunoblastic T‐cell Lymphoma
Introduction
Clinical and Biological Presentation
Epidemiology and Risk Factors, Disease Incidence and Prevalence
Basic Principles of Disease Biology
Management of Disease in the Front Line
Management of Relapsed or Refractory Disease
Future Directions
Must Reads
References
10 The Spectrum of Anaplastic Large‐cell Lymphoma
Introduction
Epidemiology and Risk Factors
Disease Incidence and Prevalence
Basic Principles of Disease Biology
Management of Disease in the Front Line
Management of the Relapsed or Refractory Patient
Future Directions
Acknowledgement
Must Reads
References
11 Human T‐cell Lymphotropic Virus Type 1 Positive Adult T‐cell Leukemia/Lymphoma
Epidemiology and Disease Incidence
Basic Principles of Disease Biology
CCR4 and Adult T‐cell Leukemia/Lymphoma
Clinical Features of Adult T‐cell Leukemia/Lymphoma
Prognosis and Prognostic Index of ATLL
Front‐line Management of Aggressive Adult T‐cell Leukemia/Lymphoma
Front‐line Management of Indolent ATLL
Management of Relapsed or Refractory Patients
Future Directions
Must Reads
References
12 Natural Killer/T‐cell Lymphomas
Introduction
Management of Newly Diagnosed Treatment‐naïve Patients
Consolidation Treatment with Hematopoietic Stem‐cell Transplantation
Management of Relapsed or Refractory Disease
Future Directions
Must Reads
References
13 T‐Prolymphocytic Leukemia
Introduction
Must Reads
References
14 Large Granular Lymphocyte Leukemia
Introduction
Epidemiology and Risk Factors
Prevalence of Concomitant Disorders
Basic Principles of Disease Biology
Management of Disease in the Front Line
Management of Relapsed or Refractory Disease
Future Directions
Funding
Must